2011 SEBIO Investor Forum Tentative Agenda (Events will be held at the Washington Duke Inn unless otherwise noted):
Tuesday, November 1, 2011
|
| 12:00pm – 7:30pm |
Registration Open
|
| 12:00pm – 12:30pm |
EARLY/Stage Advisors Lunch (Closed Session)
|
| 12:30pm – 4:30pm |
EARLY/Stage Company Mentoring Sessions (Closed Session)
|
| 5:00pm – 7:00pm |
SEBIO Board Meeting (Closed Session)
|
| 6:00pm – 8:00pm |
ibiliti medtech11 Reception (Off Site at the Sheraton Hotel, Chapel Hill)
|
| 9:00pm – 10:30pm |
Kick-Off Dessert Reception
|
|
|
Wednesday, November 2, 2011
|
| 7:00am – 5:30pm |
Registration Open
|
| 8:00am - 9:00am |
Opening Day Continental Breakfast
|
| 8:00am - 11:45am |
One-on-One Partnering Meetings
|
| 9:00am - 11:45am |
Corporate Partnering Day (Invitation Only)
Overview of Shire and the Partnering Process
9:00am – 11:00am |
| |
Shire Specialty Pharma
Barbara Deptula, Shire plc (bio)
Shire Human Genetic Therapies
Jennifer King, Shire HGT (bio)
Shire Strategic Investment Group
Brian Piper, Shire Strategic Investment Group (bio)
Shire/Advanced BioHealing
Dean Tozer, Advanced BioHealing, a Shire Company (bio) |
| |
Panel and Q&A Session: Shire's Acquisition of Advanced BioHealing
11:00am – 11:45am |
| |
Rosina Pavia, Pappas Ventures (bio) (Moderator)
Barbara Deptula, Shire plc (bio)
Gary Kurtzman, Safeguard Scientifics (bio)
Dean Tozer, Advanced BioHealing, a Shire Company (bio)
|
| 11:00am – 12:00pm |
Women in Bio Meet Up
|
| 12:00pm - 1:30pm |
Opening Luncheon and Keynote Address
Fred Eshelman, PPD (bio)
|
| 1:30pm - 6:30pm |
One-on-One Partnering Meetings
|
| 1:30pm - 4:15pm |
MAIN/Stage Company Presentations
1:30pm – 1:40pm Liquidia Technologies
1:40pm – 1:50pm Metabolon
1:50pm – 2:00pm Viamet Pharmaceuticals
2:00pm – 2:30pm Panel: Leveraging Technologies & Maximizing Opportunities |
| |
Fred Hutchison, Hutchison Law Group (bio) (Moderator)
Kyle Chenet, Liquidia Technologies, Inc.
John A.Ryals, Metabolon, Inc.
Robert J.Schotzinger, Viamet Pharmaceuticals, Inc.
|
| |
2:30pm – 2:45pm ABT Molecular Imaging
2:45pm – 3:00pm CivaTech Oncology
3:00pm – 3:15pm Altor BioScience
3:15pm – 3:45pm Panel: How Do You Interact With CROs When You Are An Early Stage Company? |
| |
Ernest Mario, Capnia (bio) (Moderator)
Chip Gillooly, Quintiles (bio)
Sridhar Mosur, Jubilant Life Sciences (bio)
Jeff Williams, Clinipace Worldwide (bio) |
| |
3:45pm – 4:00pm ELENZA, Inc.
4:00pm – 4:15pm Envoy Therapeutics
|
| 4:15pm - 4:30pm |
Break
|
| 4:30pm – 5:30pm |
Panel: From Data to Deals (and Everything in Between): What Universities and Entrepreneurs are Doing to Create Products that Matter |
| |
Christy Shaffer, Hatteras Venture Partners (bio) (Moderator)
David Day, University of Florida (bio)
Karl Normington, GlaxoSmithKline (bio)
Cam Patterson, University of North Carolina (bio)
Leon Sandler, Deshpande Center for Technological Innovation (bio)
|
| 5:30pm - 6:30pm |
EARLY/Stage Company Shootout
A panel of judges will assess four EARLY/Stage finalists on the quality of their presentation, the viability of the venture, and the overall fundability of their opportunity. The judges will score the participants and select an overall winner of the competition. The EARLY/Stage winner will be announced at the Closing Luncheon on November 3rd.
|
| 6:30pm - 8:00pm |
Gala Reception
|
| 8:00pm |
Investor Dinner (Invitation Only) |
|
| |
Thursday, November 3, 2011
|
| 6:30am – 7:30am |
5K Run
|
| 7:30am – 8:30am |
SEBIO 2012 Steering Committee Meeting (Invitation Only)
|
| 7:30am – 1:00pm |
Registration Open
|
| 8:00 am - 12:00pm |
One-on-One Partnering Meetings
|
| 8:30am - 9:30am |
Medical Device Breakfast
Cynthia L. Clark, ibiliti (bio) (Moderator)
Dennis Burns, TCG, LLC (bio)
Greg Davis, ibiliti (bio)
Fred McCoy, Synecor, LLC (bio)
|
| 8:30am - 9:30am |
Biotech/Pharma Breakfast
Edward Mathers, NEA (Moderator)
Jennifer King, Shire HGT (bio)
Ken McNish, Grifols Inc. (bio)
Sue Washer, AGTC (bio)
|
| 9:45am - 10:45am |
BIO/Plan Competition Company Presentations
Four BIO/Plan Finalists will present their business opportunity to the audience and a panel of celebrity judges. Judges will score the participants and add their scores to the earlier written development plan scores to determine the winner of the Competition. The BIO/Plan winner will be announced at the Closing Luncheon on November 3rd.
9:45am – 10:00am CureSwitch, LLC
10:00am – 10:15am Infusense, LLC
10:15am – 10:30am Transcatheter Valve Technologies
10:30am – 10:45am ViaMune, Inc.
|
|
| 10:45am - 11:00am |
Break
|
| 11:00am - 12:00pm |
Venture Capital Panel
Dennis Dougherty, Intersouth Partners (bio) (Moderator)
Kevin Bitterman, Polaris Venture Partners (bio)
Steve Hall, Lilly Ventures (bio)
Brian Underdown, Lumira Capital (bio)
|
| 12:00pm - 1:15pm |
Closing Luncheon and Keynote Address
Jim Mullen, Patheon Inc. (bio)
|
| 1:15pm - 1:45pm |
Announcement of 2011 BIO/Plan and EARLY/Stage Winners, SEBIO Awards Ceremony
|
| 2:30pm - 4:30pm |
Post-Conference Workshop: Optimizing IP Value and Understanding Financing for Emerging Companies
Thomas Allen, Wyrick Robbins Yates & Ponton LLP
Mark Feldstein, Finnegan
Mary Henninger, Finnegan
Larry Robbins, Wyrick Robbins Yates & Ponton LLP
|
